1 |
DeVault KR, Castell DO. Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease. Practice Parameters Committee of the American College of Gastroenterology[J]. Arch Intern Med, 1995, 155(20):2165-2173.
|
2 |
Gyawali CP, Kahrilas J, Savarino E, et al. Modern Diagnosis of GERD: The Lyon Consensus[J]. Gut, 2018, 67(7):1351-1362.
|
3 |
Gong Y, Zeng Q, Yan Y, et al. Association Between Lifestyle and Gastroesophageal Reflux Disease Questionnaire Scores: A Cross-Sectional Study of 37 442 Chinese Adults[J]. Gastroenterol Res Pract, 2019, 2019:5753813.
|
4 |
Yarandi SS, Nasseri-Moghaddam S, Mostajabi P, and Malekzadeh R. Overlapping Gastroesophageal Reflux Disease and Irritable Bowel Syndrome: Increased Dysfunctional Symptoms[J]. World J Gastroenterol, 2010, 16(10):1232-1238.
|
5 |
郑秀丽,莫艳波. 肠易激综合征患者中小肠细菌过度生长的研究[J]. 现代养生(下半月),2014, 16(8):32.
|
6 |
刘作静,魏慧,段丽萍,等. 肠易激综合征患者合并小肠细菌过度生长的临床特征及利福昔明治疗效果初探[J]. 中华医学杂志, 2016(24):1896-1902.
|
7 |
Ghoshal UC, Nehra A, Mathur A, et al. A Meta-Analysis on Small Intestinal Bacterial Overgrowth in Patients With Different Subtypes of Irritable Bowel Syndrome[J]. J Gastroenterol Hepatol, 2019, 35(6):14538.
|
8 |
Ghoshal UC, Shukla R, and Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge Between Functional Organic Dichotomy[J]. Gut Liver, 2017,11(2):196-208.
|
9 |
Scarpellini E, Giorgio V, Gabrielli M, et al. Rifaximin Treatment for Small Intestinal Bacterial Overgrowth in Children With Irritable Bowel Syndrome[J]. Eur Rev Med Pharmacol Sci, 2013, 17(10):1314-1320.
|
10 |
Pimentel M. Review of Rifaximin as Treatment for SIBO and IBS[J]. Expert OpinInvestig Drugs, 2009, 18(3):349-358.
|
11 |
Pimentel M. Review Article: Potential Mechanisms of Action of Rifaximin in the Management of Irritable Bowel Syndrome With Diarrhoea[J]. Aliment Pharmacol Ther, 2016, 43 Suppl 1:37-49.
|
12 |
Ha NR, Lee HL, Lee OY, et al. Differences in Clinical Characteristics Between Patients With Non-Erosive Reflux Disease and Erosive Esophagitis in Korea[J]. J Korean Med Sci, 2010, 25(9):1318-1322.
|
13 |
Kim K, Kim B, Lee B, et al. Erosive Esophagitis May Be Related to Small Intestinal Bacterial Overgrowth[J]. Scand J Gastroenterol, 2012, 47(5):493-498.
|
14 |
Lasser RB, Bond JH, Levitt MD. The Role of Intestinal Gas in Functional Abdominal Pain[J]. N Engl J Med, 1975, 293(11):524-526.
|
15 |
Bornschein W, Staber F, Buttermann G. Endoscopic Intragastric Detection of Hydrogen[J]. Z Gastroenterol, 1986, 24(12):722-731.
|
16 |
Piche T, Zerbib F, Varannes SB, et al., Modulation by Colonic Fermentation of LES Function in Humans. Am J PhysiolGastrointest Liver Physiol. 2000 Apr; 278(4):G578-84.
|
17 |
Urita Y, Sugimoto M, Hike K, et al. High Incidence of Fermentation in the Digestive Tract in Patients With Reflux Oesophagitis[J]. Eur J Gastroenterol Hepatol, 2006, 18(5):531-535.
|
18 |
Urita Y, Ishihara S, Akimoto T, et al. Hydrogen and Methane Gases Are Frequently Detected in the Stomach[J]. World J Gastroenterol, 2006, 12(19):3088-30891.
|
19 |
Piche T, des Varannes SB, Sacher-Huvelin S, et al. Colonic Fermentation Influences Lower Esophageal Sphincter Function in Gastroesophageal Reflux Disease[J]. Gastroenterology, 2003, 124(4):894-902.
|
20 |
Dodds WJ, Dent J, Hogan WJ. Mechanisms of Gastroesophageal Reflux in Patients With Reflux Esophagitis. N Engl J Med. 1982, 307(25):1547-1552.
|
|
Ghoshal UC, Srivastava D. Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype. World J Gastroenterol. 2014;20:2482-2491.
|